medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2023, Number 06

<< Back Next >>

Ginecol Obstet Mex 2023; 91 (06)

Asymptomatic bacteriuria in pregnancy. Cases series in a private clinic in Uruapan Michoacán

Zalapa-Ríos R, Zalapa-Gómez MF

Language: Spanish
References: 22
Page: 395-401
PDF size: 345.87 Kb.


ABSTRACT

Objective: To determine the prevalence of asymptomatic bacteriuria, its adequate treatment based on the antibiogram report of pregnant patients who attended prenatal control in a private clinic.
Materials and Methods: Retrospective study of a case series, descriptive and cross-sectional carried out in pregnant women who attended prenatal control in the outpatient clinic of the Hospital Fray Juan de San Miguel de Uruapan, Michoacán, between January 1, 2019 and December 31, 2021. Study variables: mothers' age, weeks of pregnancy, pregnancies, bacteriuria, causative agent, indicated antibiotic and response to treatment. Descriptive statistics, measures of central tendency and simple frequencies were used to interpret the results obtained.
Results: A total of 227 pregnant women were studied; 49 of them had a positive urine culture. The prevalence of asymptomatic bacteriuria was 21.59. Escherichia coli was the most reported causative agent. Of the control urine cultures 36 of 37 were negative and only 1 of 37 was positive.
Conclusion: The prevalence of asymptomatic bacteriuria in this study was 21.59% and the main etiologic agent was E. coli in most cases, with sensitivity to nitrofurantoin in most cases.


REFERENCES

  1. Cortés Enríquez OD., Torres González JH. Prevalencia,factores de riesgo y tratamiento de la infección de víasurinarias en mujeres embarazadas. Revista Salud Públicay Nutrición 2022; 21 (4): 1-11. https://doi.org/10.29105/respyn21.4-684

  2. Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guidelinefor the management of asymptomatic bacteriuria:2019 Update by the Infectious Diseases Society of America.Clin Infect Dis 2019; 68: e83. doi: https://doi.org/10.1093/cid/ciy1121

  3. Hernández BF. Frecuencia de bacteriuria asintomática enembarazadas y sensibilidad antimicrobiana in vitro de losuropatógenos. Ginecol Obstet Mex 2007; 75: 325-331.

  4. Autún Rosado DP, Sanabria Padrón VH, Cortés FigueroaEH, Rangel Villaseñor O, Hernández-Valencia M. Etiologíay frecuencia de bacteriuria asintomática en mujeresembarazadas. Perinatol y Rep Hum 2015; 29 (4): 149.doi: 10.1016/j.rprh.2016.02.001

  5. Smaill FM, Vazquez JC. Antibiotics for asymptomatic bacteriuriain pregnancy. Cochrane Database Syst Rev. 2019Nov 25; 2019 (11): CD000490. doi: 10.1002/14651858

  6. Moore A, Doull M, Grad R, Groulx S, Pottie K, Tonelli M,Courage S, Garcia AJ, Thombs BD; Canadian Task Force onPreventive Health Care. Recommendations on screeningfor asymptomatic bacteriuria in pregnancy. CMAJ 2018;190 (27): E823-E830. doi:10.1503/cmaj.171325

  7. Henderson JT, Webber EM, Bean SI. Screening for asymptomaticbacteriuria in adults: updated evidence report andsystematic review for the US Preventive Services Task Force.JAMA 2019; 322 (12): 1195-205. doi: 10.1001/jama.2019

  8. Wingert A, Pillay J, Sebastianski M, Gates M, FeatherstoneR, Shave K, et al. Asymptomatic bacteriuria in pregnancy:systematic reviews of screening and treatment effectivenessand patient preferences. BMJ Open 2019; 9: e021347.doi:10.1136/bmjopen-2017-021347

  9. Guía de Práctica Clínica, Estados Unidos Mexicanos,Gobierno Federal, Número de Registro: IMSS 078-08,Diagnóstico y tratamiento de la infección del tracto urinariobajo durante el embarazo, en un primer nivel deatención 2016. https://www.imss.gob.mx/sites/all/statics/guiasclinicas/078GER.pdf

  10. US Preventive Services Task Force, Owens DK, DavidsonKW, Krist AH, Barry MJ, et al. Screening for asymptomaticbacteriuria in adults: US Preventive Services Task ForceRecommendation Statement. JAMA 2019; 322 (12): 1188-94. doi: 10.1001/jama

  11. Canadian Task Force on Preventive Health Care. Asymptomaticbacteriuria in pregnancy. 2018. Retrieved from:https://canadiantaskforce.ca/guidelines/publishedguidelines/asymptomatic-bacteriuria/

  12. Millar L, DeBuque L, Leialoha C, Grandinetti A, Killeen J.Rapid enzymatic urine screening test to detect bacteriuriain pregnancy. Obstet Gynecol 2000; 95 (4): 601-604. doi:10.1016/s0029-7844(99)00597-9

  13. McNair RD, MacDonald SR, Dooley SL, Peterson LR. Evaluationof the centrifuged and Gram-stained smear, urinalysis,and reagent strip testing to detect asymptomatic bacteriuriain obstetric patients. Am J Obstet Gynecol 2000; 182(5): 1076-9. doi: 10.1067/mob.2000.105440

  14. Shelton SD, Boggess KA, Kirvan K, Sedor F, Herbert WN.Urinary interleukin-8 with asymptomatic bacteriuriain pregnancy. Obstet Gynecol 2001; 97 (4): 583-6. doi:10.1016/s0029-7844(00)01226-6

  15. Keating GM. Fosfomycin trometamol: a review of its useas a single-dose oral treatment for patients with acutelower urinary tract infections and pregnant women withasymptomatic bacteriuria. Drugs 2013; 73 (17): 1951-66.doi: 10.1007/s40265-013-0143-y

  16. Kazemier BM, Koningstein FN, Schneeberger C, Ott A,Bossuyt PM, de Miranda E, et al. Maternal and neonatalconsequences of treated and untreated asymptomaticbacteriuria in pregnancy: a prospective cohort studywith an embedded randomized controlled trial. LancetInfect Dis 2015; 15 (11): 1324-33. doi: 10.1016/S1473-3099(15)00070-5

  17. Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ.Antibacterial medication use during pregnancy and risk ofbirth defects: National Birth Defects Prevention Study. ArchPediatr Adolesc Med 2009; 163 (11): 978-85. doi: 10.1001/archpediatrics.2009.188

  18. Ailes EC, Gilboa SM, Gill SK, Broussard CS, Crider KS, BerryRJ, Carter TC, Hobbs CA, Interrante JD, Reefhuis J; and TheNational Birth Defects Prevention Study. Association betweenantibiotic use among pregnant women with urinarytract infections in the first trimester and birth defects,National Birth Defects Prevention Study 1997 to 2011. BirthDefects Res A Clin Mol Teratol 2016; 106 (11): 940-49. doi:10.1002/bdra.23570

  19. Ben David S, Einarson T, Ben David Y, Nulman I, PastuszakA, Koren G. The safety of nitrofurantoin during the firsttrimester of pregnancy: meta-analysis. Fundam Clin Pharmacol1995; 9 (5): 503-7. doi: 10.1111/j.1472-8206.1995.tb00525.x

  20. Le J, Briggs GG, McKeown A, Bustillo G. Urinary tract infectionsduring pregnancy. Ann Pharmacother 2004; 38 (10):1692-701. doi: 10.1345/aph.1D630

  21. Sandberg T, Brorson JE. Efficacy of long-term antimicrobialprophylaxis after acute pyelonephritis inpregnancy. Scand J Infect Dis 1991; 23 (2): 221-3. doi:10.3109/00365549109023404

  22. Vallano A, Arnau JM. Antimicrobianos y embarazo. EnfermedadesInfecciosas y Microbiología 2009; 27 (9): 536-42.doi:10.1016/j.eimc.2009.09.001




2020     |     www.medigraphic.com